A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
100 项与 Debio 4228 相关的临床结果
100 项与 Debio 4228 相关的转化医学
100 项与 Debio 4228 相关的专利(医药)
100 项与 Debio 4228 相关的药物交易